|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 97.49 USD | +1.39% |
|
-0.72% | +22.40% |
| 01-29 | Revolution Medicines Says First Patient Dosed in Solid Tumor Trial | MT |
| 01-29 | Revolution Medicines Doses First Patient in Clinical Trial Evaluating RMC-5127, a RAS(ON) G12V-Selective Inhibitor | CI |
Main competitors
| Change | 5d. change | 1 months change | 3 months change | Varia. Jan 1. | 1-year change | 3-years change | 5-years change | 10-years change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1.39% | -0.72% | +24.46% | +64.29% | +22.40% | +120.32% | +276.41% | +83.15% | - | 18.59B | |
| -0.19% | -3.15% | -3.44% | -3.94% | -3.83% | -15.63% | -6.37% | -8.13% | +252.80% | 46.79B | |
| +1.99% | +1.12% | +10.50% | +10.12% | +16.49% | +55.45% | +37.77% | -4.83% | +943.70% | 38.4B | |
| +3.61% | -20.43% | -20.08% | -10.77% | -16.82% | -8.74% | -20.95% | +0.75% | +226.07% | 30.69B | |
| +1.15% | +2.56% | +5.01% | +25.79% | +21.55% | +28.32% | +42.07% | -25.37% | +149.72% | 32.5B | |
| +0.14% | -8.60% | -7.63% | -9.48% | -3.49% | +52.62% | +129.60% | +268.61% | - | 15.25B | |
| -0.67% | +2.72% | +1.28% | +15.14% | +8.97% | +32.14% | -4.44% | -15.57% | +136.85% | 14.25B | |
| +8.62% | -2.38% | +0.70% | +107.86% | +29.67% | +27,048.55% | +3,395.96% | - | - | 12.4B | |
| +3.62% | +3.12% | +10.15% | +15.83% | +9.34% | +160.78% | +111.39% | +43.71% | +144.42% | 13.52B | |
| +2.19% | -0.80% | +4.22% | +12.34% | +4.18% | +71.66% | +91.34% | +45.46% | +1,074.78% | 13.34B | |
| +3.58% | -18.99% | -23.78% | -8.01% | -17.36% | -23.33% | -38.29% | -24.77% | +123.00% | 11.1B | |
| +1.40% | +4.38% | +5.95% | +11.41% | +13.55% | -11.26% | -15.64% | -29.83% | +205.18% | 10.26B | |
| -0.55% | -5.14% | +4.11% | +9.88% | +7.63% | +10.51% | -7.86% | -15.52% | +108.81% | 10.56B | |
| +3.00% | -10.62% | -9.17% | +12.83% | -5.15% | +14.07% | -24.42% | -31.39% | +170.07% | 9.04B | |
| +4.71% | -13.54% | -15.13% | -33.25% | -7.01% | -20.63% | - | - | - | 9.33B | |
| +1.47% | +1.04% | -6.65% | +13.87% | -19.52% | +1,605.99% | +1,229.22% | +202.81% | +527.18% | 8.76B | |
| +4.56% | +1.68% | +15.40% | +94.10% | +8.42% | +262.20% | +359.15% | -60.26% | - | 8.48B | |
| +0.14% | -.--% | -.--% | -.--% | -.--% | +17.30% | +183.59% | +26.92% | +768.86% | 8.38B | |
| +3.06% | +11.44% | +10.95% | +12.15% | +15.78% | +32.57% | -44.60% | -63.90% | +252.70% | 7.56B | |
| -0.30% | -0.07% | +0.33% | -5.83% | +6.23% | +19.79% | -39.37% | -55.79% | - | 7.39B | |
| Average | +2.15% | -4.19% | +0.36% | +16.72% | +4.55% | +1,472.64% | +297.61% | +18.67% | +363.15% | 16.33B | |
| Weighted average by Cap. | +1.87% | -4.22% | +0.37% | +14.09% | +5.08% | +1,103.85% | +213.05% | +15.80% | +381.11% |
- Stock Market
- Equities
- RVMD Stock
- Sector Revolution Medicines, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition